Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics

被引:48
作者
Mooij, Miriam G. [1 ,2 ]
Nies, Anne T. [3 ,4 ]
Knibbe, Catherijne A. J. [5 ,6 ]
Schaeffeler, Elke [3 ,4 ]
Tibboel, Dick [1 ,2 ]
Schwab, Matthias [3 ,7 ]
de Wildt, Saskia N. [1 ,2 ]
机构
[1] Erasmus MC Sophia Childrens Hosp, Intens Care, Room Sp 3458,Wytemaweg 80,POB 2060, NL-3000 CB Rotterdam, Netherlands
[2] Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Room Sp 3458,Wytemaweg 80,POB 2060, NL-3000 CB Rotterdam, Netherlands
[3] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
[4] Univ Tubingen, Tubingen, Germany
[5] Leiden Acad Ctr Res Pharmacol, Fac Sci, Leiden, Netherlands
[6] St Antonius Hosp, Hosp Pharm & Clin Pharmacol, Nieuwegein, Netherlands
[7] Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany
关键词
MESSENGER-RNA EXPRESSION; TACROLIMUS DOSING REQUIREMENTS; SINGLE-DOSE PHARMACOKINETICS; P-GLYCOPROTEIN EXPRESSION; FAMILIAL HYPERCHOLESTEROLEMIA; POPULATION PHARMACOKINETICS; INTERINDIVIDUAL VARIABILITY; GENETIC POLYMORPHISMS; METABOLIZING-ENZYMES; DOSAGE REQUIREMENTS;
D O I
10.1007/s40262-015-0328-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Membrane transporters play an essential role in the transport of endogenous and exogenous compounds, and consequently they mediate the uptake, distribution, and excretion of many drugs. The clinical relevance of transporters in drug disposition and their effect in adults have been shown in drug-drug interaction and pharmacogenomic studies. Little is known, however, about the ontogeny of human membrane transporters and their roles in pediatric pharmacotherapy. As they are involved in the transport of endogenous substrates, growth and development may be important determinants of their expression and activity. This review presents an overview of our current knowledge on human membrane transporters in pediatric drug disposition and effect. Existing pharmacokinetic and pharmacogenetic data on membrane substrate drugs frequently used in children are presented and related, where possible, to existing ex vivo data, providing a basis for developmental patterns for individual human membrane transporters. As data for individual transporters are currently still scarce, there is a striking information gap regarding the role of human membrane transporters in drug therapy in children.
引用
收藏
页码:507 / 524
页数:18
相关论文
共 50 条
[41]   Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG [J].
Brian, William ;
Tremaine, Larry M. ;
Arefayene, Million ;
de Kanter, Ruben ;
Evers, Raymond ;
Guo, Yingying ;
Kalabus, James ;
Lin, Wen ;
Loi, Cho-Ming ;
Xiao, Guangqing .
PHARMACOGENOMICS, 2016, 17 (06) :615-631
[42]   The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers [J].
Yamada, Akihiro ;
Maeda, Kazuya ;
Ishiguro, Naoki ;
Tsuda, Yasuhiro ;
Igarashi, Takashi ;
Ebner, Thomas ;
Roth, Willy ;
Ikushiro, Shinichi ;
Sugiyama, Yuichi .
PHARMACOGENETICS AND GENOMICS, 2011, 21 (09) :523-530
[43]   Caco-2 cells - expression, regulation and function of drug transporters compared with human jejunal tissue [J].
Bruck, S. ;
Strohmeier, J. ;
Busch, D. ;
Drozdzik, M. ;
Oswald, S. .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2017, 38 (02) :115-126
[44]   High Impact of Oatp1a/1b Transporters on In Vivo Disposition of the Hydrophobic Anticancer Drug Paclitaxel [J].
van de Steeg, Evita ;
van Esch, Anita ;
Wagenaar, Els ;
van der Kruijssen, Cornelia M. M. ;
van Tellingen, Olaf ;
Kenworthy, Kathryn E. ;
Schinkel, Alfred H. .
CLINICAL CANCER RESEARCH, 2011, 17 (02) :294-301
[45]   Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase Inhibitors [J].
Neul, Claudia ;
Schaeffeler, Elke ;
Sparreboom, Alex ;
Laufer, Stefan ;
Schwab, Matthias ;
Nies, Anne T. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2016, 37 (11) :904-932
[46]   Pharmacogenetics of human sulfotransferases and impact of amino acid exchange on Phase II drug metabolism [J].
Isvoran, Adriana ;
Peng, Yunhui ;
Ceauranu, Silvana ;
Schmidt, Leon ;
Nicot, Arnaud B. ;
Miteva, Maria A. .
DRUG DISCOVERY TODAY, 2022, 27 (11)
[47]   Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption [J].
Harwood, M. D. ;
Neuhoff, S. ;
Carlson, G. L. ;
Warhurst, G. ;
Rostami-Hodjegan, A. .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2013, 34 (01) :2-28
[48]   Protein Abundance of Clinically Relevant Drug Transporters in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens [J].
Drozdzik, Marek ;
Busch, Diana ;
Oswald, Stefan ;
Lapczuk, Joanna ;
Muller, Janett ;
Ostrowski, Marek ;
Kurzawski, Mateusz .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (05) :1204-1212
[49]   Expression, regulation and function of intestinal drug transporters: an update [J].
Mueller, Janett ;
Keiser, Markus ;
Drozdzik, Marek ;
Oswald, Stefan .
BIOLOGICAL CHEMISTRY, 2017, 398 (02) :175-192
[50]   Interindividual variability in statin pharmacokinetics and effects of drug transporters [J].
Hirota, Takeshi ;
Ieiri, Ichiro .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (1-2) :37-43